Monday, 30 March 2020

Sanofi, Regeneron expand testing of potential coronavirus treatment

Sanofi and Regeneron Pharmaceuticals Inc have expanded a clinical trial of their rheumatoid arthritis drug Kevzara as a coronavirus treatment to patients outside the United States.


No comments:

Post a Comment